Verified IDREGNRegeneron Pharmaceuticals, Inc.Pharmaceuticals & BiotechFollowSaveShareFederal commitments · 12m$279MCommitments / revenue1.7%Contracts ending · 18mFull contract value$279MAsk IntelSource-backedSuggested question →What could these expiring contracts mean for Regeneron Pharmaceuticals's future?Ask your own question→Full intelligence →Records as of 17 Nov 2026.